With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.15529-49-4,Dichlorotris(triphenylphosphino)ruthenium (II),as a common compound, the synthetic route is as follows.
RuCl2(PPh3)3(480 mg, 0.5 mmol) was placed in a 25 mL flask filled with argon. THF(12.5 mL) and (R,R)-DPEN (127 mg, 0.6 mmol) were then added. The mixturewas degassed and stirred under argon at 25 oC for 6 h. After removalof turbidity by filtration, n-hexane (30 mL) was added, and a light yellowsolid was obtained. The supernatant was removed and the resulting solid wasdried under reduced pressure to give analytically pure 1f (442 mg, 97% yield). 2.1. RuCl2(R,R)-DPEN(PPh3)2 1f1H NMR (300MHz, C6D6, ppm), delta: 7.95-7.92 (m,12H), 6.97-6.95 (m, 18H), 6.74 (br, 10H), 4.61-4.4.59(m, 2H), 4.12-4.09 (m, 2H), 3.59-3.56 (m, 2H); 31P NMR (121MHz, C6D6, ppm), delta: 45.7.
The synthetic route of 15529-49-4 has been constantly updated, and we look forward to future research findings.
Reference£º
Article; Li, Xuefeng; Ma, Yaping; Xing, Zhikui; Tang, Ning; Zhu, Jin; Deng, Jingen; Tetrahedron Letters; vol. 55; 29; (2014); p. 3868 – 3872;,
Highly efficient and robust molecular ruthenium catalysts for water oxidation
Catalysts | Special Issue : Ruthenium Catalysts – MDPI